Our 2004 Summit was a success thanks to your participation and support! For those unable to join us this year we are busy preparing the 2004 Summit highlights for publication on our website. Check back with us here and in the meantime enjoy your visit to our website.
Young Scientists Receive HFIs Research Awards
HCV Killer Cells
Linked to Genes
Kudos for HFIs Training of Drug Abuse Counselors
Following the training session presented by Thelma King Thiel, CEO of HFI, Dr. David G. Ostrow, MD, PhD, an addictionologist commented, “Your inspirational advice and videos were all rated highly by the participants and, in particular, they appreciated your cultural sensitivity.”
Eighty-nine percent of attendees reported that the effectiveness of Ms. Thiel’s liver wellness approach and communication techniques was extremely relevant or very relevant to their clinical practice. Ninety-seven percent of participants reported that they learned something new about the liver from the workshop. Sixty- six percent of participants were unaware that the liver functions to provide energy and many life preserving activities essential to daily living. The counselors reported that they were most impressed to learn that viral hepatitis is both easily transmitted and easily prevented. Seventy- nine percent of the counselors indicated that the information presented caused them concern that they or a loved one could have unknowingly been exposed to viral hepatitis. Eighty-seven percent expressed interest in a hepatitis B vaccination for themselves or their family members to protect them form contracting this highly infectious virus.
Counselors indicated that all of the information presented at the workshop would be helpful to them in dealing with their clients. When asked if they would share the information that they learned at the workshop, one hundred percent of the workshop participants said “yes”. For information about HFI’s Train-the-Trainer program call 800-891-0707.
January 2004, Bethesda, MD: NEW REPORT ON
Hepatitis Foundation International unveils Heplink, a new web site providing deep web search portal on topics of interest to you on viral hepatitis.
News and Medical Updates on Hepatitis from the AASLD 2003 Meetings. Visit HCV Advocate now!
January 8, 2004, Nutley, N.J. -- Roche announces the FDA approval of the availability of Pegasys in a pre-filled syringe.
This page Bobby Approved